TCM
Traynor Capital Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-22,730
| Closed | -$6.43M | – | 225 |
|
|
2021
Q3 | $6.43M | Sell |
22,730
-2,353
| -9% | -$666K | 0.88% | 25 |
|
|
2021
Q2 | $8.75M | Sell |
25,083
-2,221
| -8% | -$774K | 1.22% | 18 |
|
|
2021
Q1 | $7.64M | Buy |
27,304
+899
| +3% | +$251K | 1.26% | 20 |
|
|
2020
Q4 | $6.47M | Buy |
26,405
+3,320
| +14% | +$813K | 1.15% | 22 |
|
|
2020
Q3 | $6.12M | Sell |
23,085
-446
| -2% | -$118K | 1.4% | 12 |
|
|
2020
Q2 | $6.3M | Buy |
23,531
+4,073
| +21% | +$1.09M | 1.52% | 10 |
|
|
2020
Q1 | $6.16M | Buy |
19,458
+2,940
| +18% | +$930K | 2.19% | 10 |
|
|
2019
Q4 | $4.9M | Sell |
16,518
-212
| -1% | -$62.9K | 1.31% | 18 |
|
|
2019
Q3 | $3.9M | Sell |
16,730
-305
| -2% | -$71K | 1.22% | 19 |
|
|
2019
Q2 | $4.01M | Buy |
17,035
+2,972
| +21% | +$700K | 1.3% | 16 |
|
|
2019
Q1 | $3.32M | Buy |
14,063
+4,094
| +41% | +$967K | 1.11% | 22 |
|
|
2018
Q4 | $3M | Buy |
9,969
+568
| +6% | +$171K | 1.25% | 18 |
|
|
2018
Q3 | $3.32M | Buy |
9,401
+337
| +4% | +$119K | 1.08% | 19 |
|
|
2018
Q2 | $2.68M | Buy |
9,064
+440
| +5% | +$130K | 0.98% | 21 |
|
|
2018
Q1 | $2.36M | Buy |
8,624
+1,760
| +26% | +$482K | 0.96% | 23 |
|
|
2017
Q4 | $2.19M | Buy |
6,864
+1,481
| +28% | +$472K | 0.93% | 26 |
|
|
2017
Q3 | $1.67M | Buy |
5,383
+338
| +7% | +$105K | 0.79% | 28 |
|
|
2017
Q2 | $1.44M | Buy |
5,045
+1,329
| +36% | +$380K | 0.71% | 32 |
|
|
2017
Q1 | $1.01M | Buy |
3,716
+1,160
| +45% | +$315K | 0.56% | 37 |
|
|
2016
Q4 | $705K | Buy |
2,556
+459
| +22% | +$127K | 0.47% | 45 |
|
|
2016
Q3 | $618K | Buy |
2,097
+247
| +13% | +$72.8K | 0.44% | 51 |
|
|
2016
Q2 | $447K | Sell |
1,850
-1,070
| -37% | -$259K | 0.35% | 63 |
|
|
2016
Q1 | $760K | Sell |
2,920
-267
| -8% | -$69.5K | 0.61% | 37 |
|
|
2015
Q4 | $976K | Sell |
3,187
-104
| -3% | -$31.8K | 0.7% | 35 |
|
|
2015
Q3 | $960K | Buy |
3,291
+1,311
| +66% | +$382K | 0.83% | 26 |
|
|
2015
Q2 | $799K | Buy |
+1,980
| New | +$799K | 0.67% | 32 |
|